Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial.

about

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial.

Item

http://www.wikidata.org/entity/Q47109230

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Granulocyte colony-stimulating ...... sed, controlled phase 2 trial.

@en

Granulocyte colony-stimulating ...... sed, controlled phase 2 trial.

@nl

type

Item

label

Granulocyte colony-stimulating ...... sed, controlled phase 2 trial.

@en

Granulocyte colony-stimulating ...... sed, controlled phase 2 trial.

@nl

prefLabel

Granulocyte colony-stimulating ...... sed, controlled phase 2 trial.

@en

Granulocyte colony-stimulating ...... sed, controlled phase 2 trial.

@nl

P1476

Granulocyte colony-stimulating ...... sed, controlled phase 2 trial.

@en

P2093

Andrew L King

http://www.w3.org/2001/XMLSchema#string

Anne Atkinson

http://www.w3.org/2001/XMLSchema#string

Carol Bienek

http://www.w3.org/2001/XMLSchema#string

Christopher Corbett

http://www.w3.org/2001/XMLSchema#string

Dan Hollyman

http://www.w3.org/2001/XMLSchema#string

Deborah Stocken

http://www.w3.org/2001/XMLSchema#string

Diana Hull

http://www.w3.org/2001/XMLSchema#string

Heather A Beard

http://www.w3.org/2001/XMLSchema#string

Jacqui Thompson

http://www.w3.org/2001/XMLSchema#string

Joanna Moore

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review: the effects of autologous stem cell therapy for patients with liver disease

Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate data.

Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice.

Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease.

Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study.

Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?

Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis.

Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis.

Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease.

Vision Loss after Intravitreal Injection of Autologous "Stem Cells" for AMD.

P304

25-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S2468-1253(17)30326-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29127060

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

P932

5738975

http://www.w3.org/2001/XMLSchema#string